Top compounds associated with response to LRFN2

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	Docetaxel	GDSC1000	pan-cancer	AAC	-0.15	3e-06
mRNA	Doxorubicin	gCSI	pan-cancer	AAC	-0.23	1e-05
mRNA	BRD-A02303741:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.16	1e-05
mRNA	BRD-K88742110	CTRPv2	pan-cancer	AAC	0.16	2e-05
mRNA	PX-12	CTRPv2	pan-cancer	AAC	0.12	4e-05
mRNA	serdemetan:SCH-529074 (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.14	4e-05
mRNA	KIN001-102	GDSC1000	pan-cancer	AAC	0.12	5e-05
mRNA	BRD-K34222889	CTRPv2	pan-cancer	AAC	0.13	6e-05
mRNA	vorinostat:navitoclax (4:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.14	9e-05
mRNA	PD-0325901	gCSI	pan-cancer	AAC	-0.2	0.0001

Download CSV